These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4291164)

  • 21. ACTIVATION OF THE FIBRIN STABILIZING FACTOR OF PLASMA BY THROMBIN.
    LORAND L; KONISHI K
    Arch Biochem Biophys; 1964 Apr; 105():58-67. PubMed ID: 14165504
    [No Abstract]   [Full Text] [Related]  

  • 22. Transamidase activity of the enzyme responsible for insoluble fibrin formation.
    Loewy AG; Matacić S; Darnell JH
    Arch Biochem Biophys; 1966 Feb; 113(2):435-8. PubMed ID: 5941202
    [No Abstract]   [Full Text] [Related]  

  • 23. [Fibrin stabilization and fibrinolysis in total wound dehiscence].
    Cassau D; Siewert R; Osten W
    Chirurg; 1969 Feb; 40(2):76-80. PubMed ID: 5350850
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessment of thrombogenicity of prothrombin complex concentrates in a porcine model.
    Harrison J; Abildgaard C; Lazerson J; Culbertson R; Anderson G
    Thromb Res; 1985 Apr; 38(2):173-88. PubMed ID: 4002204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of thrombin cleavage of plasma factor XIII bound to fibrin.
    Greenberg CS; Achyuthan KE; Miraglia CC; Dobson JV
    Ann N Y Acad Sci; 1986; 485():140-3. PubMed ID: 3471145
    [No Abstract]   [Full Text] [Related]  

  • 26. [THE FIBRIN-STABILIZING FACTOR].
    GORMSEN J
    Ugeskr Laeger; 1964 Oct; 126():1417-22. PubMed ID: 14240318
    [No Abstract]   [Full Text] [Related]  

  • 27. Physiological inhibition of factor XIII.
    de Cataldo F; Baudo F
    Ann N Y Acad Sci; 1972 Dec; 202():341-3. PubMed ID: 4508932
    [No Abstract]   [Full Text] [Related]  

  • 28. [Results of an experimental study of the pharmacokinetics of polymyxin B sulfate].
    Vasil'ev VK; Koroleva VG
    Antibiotiki; 1976 Jul; 21(7):621-4. PubMed ID: 182072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ex vivo reversibility of dabigatran-induced whole-blood coagulopathy as monitored by thromboelastography: mechanistic implications for clinical medicine.
    Davis PK; Musunuru H; Walsh M; Mitra R; Ploplis V; Castellino FJ
    Thromb Haemost; 2012 Sep; 108(3):586-8. PubMed ID: 22782135
    [No Abstract]   [Full Text] [Related]  

  • 30. [Activation mechanism of bovine factor XII on foreign surfaces--activation by polysaccharide sulfate and sulfatide and inhibition by platelet components].
    Kato H; Shimada T; Ohno Y; Sugo T; Kodama K
    Rinsho Byori; 1982 Jun; Suppl 50():102-13. PubMed ID: 6215509
    [No Abstract]   [Full Text] [Related]  

  • 31. Fibrin-stabilizing factor inhibitors.
    Nilsson JL; Stenberg P; Ljunggren C; Hoffman KJ; Lundén R; Eriksson O; Lorand L
    Ann N Y Acad Sci; 1972 Dec; 202():286-96. PubMed ID: 4508928
    [No Abstract]   [Full Text] [Related]  

  • 32. [BEHAVIOR OF FIBRIN STABILIZING FACTOR IN LIVER DISEASES].
    OTTAVIANI P; MANDELLI F; FONTANA L; MORELLI R
    Prog Med (Napoli); 1965 Feb; 21():115-20. PubMed ID: 14340535
    [No Abstract]   [Full Text] [Related]  

  • 33. [Action of phospholipase A on fibrin formation].
    Thomas JA; Migne J; Gineste J; Henry M; Ducros MC
    C R Acad Hebd Seances Acad Sci D; 1969 Apr; 268(14):1860-3. PubMed ID: 4977303
    [No Abstract]   [Full Text] [Related]  

  • 34. [Coagulation physiology research in a new coagulation disorder. Deficiency of a fibrin-stabilizing factor].
    DUCKERT F; JUNG E; SHMERLING DH
    Schweiz Med Wochenschr; 1961 Sep; 91():1139-40. PubMed ID: 13888166
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of the cross-linking patterns of lamprey fibrinogen and fibrin by the action of the intrinsic lamprey factor XIII and human factor XIII during the process of blood coagulation.
    Murtaugh PA
    Thromb Haemost; 1977 Aug; 38(2):429-37. PubMed ID: 579486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of hemolysates on the coagulation of rabbit plasma].
    Lambert PH
    C R Seances Soc Biol Fil; 1966; 160(1):202-4. PubMed ID: 4222920
    [No Abstract]   [Full Text] [Related]  

  • 37. Enzymatic basis for platelet aggregation and release: the significance of the 'platelet atmosphere' and the relationship between platelet function and blood coagulation.
    Ardlie NG; Han P
    Br J Haematol; 1974 Mar; 26(3):331-56. PubMed ID: 4851871
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of high purity factor IX concentrates and a prothrombin complex concentrate in a canine model of thrombogenicity.
    MacGregor IR; Ferguson JM; McLaughlin LF; Burnouf T; Prowse CV
    Thromb Haemost; 1991 Nov; 66(5):609-13. PubMed ID: 1803625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fibrinase: its role in hemostasis].
    Baluda VP
    Lab Delo; 1968; 6():355-9. PubMed ID: 4184650
    [No Abstract]   [Full Text] [Related]  

  • 40. [ON THE PLASMA CONTENT OF FIBRIN-STABILIZING FACTOR (FSF) IN VARIOUS LIFE PERIODS].
    STROEDER J
    Klin Wochenschr; 1964 Jul; 42():649-50. PubMed ID: 14248616
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.